• Company
• Sales of Nexavar fell sharply
• by Jun 8, 2022 05:55am

• Policy
• The price gap between Memantine products is more than 2.5x
• by Lee, Tak-Sun Jun 7, 2022 06:04am

• Company
• Neutropenia drugs' sales affected by their sales partners
• by Chon, Seung-Hyun Jun 7, 2022 06:04am

• Company
• Emgality passes DREC review… what about Ajovy?
• by Eo, Yun-Ho Jun 7, 2022 06:04am

• Policy
• Price Negotiation for One-shot Treatment Zolgensma
• by Lee, Tak-Sun Jun 7, 2022 06:04am

• Company
• Cumulative sales of Spinraza in 3yrs is ₩200 billion
• by Chon, Seung-Hyun Jun 7, 2022 06:03am

• Company
• Bio USA to be held offline for the first time in 3 years
• by Kim, Jin-Gu Jun 3, 2022 06:37am

• Company
• Pharmas succeed in additionally avoiding Entresto patent
• by Kim, Jin-Gu Jun 3, 2022 06:37am

• Company
• 10 years since stem cell therapy was introduced
• by Chon, Seung-Hyun Jun 3, 2022 06:36am

• Company
• Dukarb of Huons won the patent battle
• by Kim, Jin-Gu Jun 3, 2022 06:36am